Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF730 | SNV | Missense_Mutation | | c.395N>T | p.Arg132Ile | p.R132I | Q6ZMV8 | protein_coding | deleterious(0.04) | benign(0.136) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.1231N>A | p.Leu411Ile | p.L411I | Q6ZMV8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
ZNF730 | SNV | Missense_Mutation | | c.961T>C | p.Phe321Leu | p.F321L | Q6ZMV8 | protein_coding | deleterious(0.01) | probably_damaging(0.993) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.1185T>G | p.Phe395Leu | p.F395L | Q6ZMV8 | protein_coding | tolerated(0.08) | benign(0.001) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF730 | SNV | Missense_Mutation | | c.1496A>C | p.Lys499Thr | p.K499T | Q6ZMV8 | protein_coding | deleterious(0.01) | possibly_damaging(0.849) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.620G>A | p.Gly207Asp | p.G207D | Q6ZMV8 | protein_coding | deleterious(0.04) | benign(0.415) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.1077N>T | p.Lys359Asn | p.K359N | Q6ZMV8 | protein_coding | deleterious(0.03) | benign(0.267) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
ZNF730 | SNV | Missense_Mutation | novel | c.285N>A | p.Phe95Leu | p.F95L | Q6ZMV8 | protein_coding | tolerated(0.19) | benign(0.114) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.454N>G | p.Lys152Glu | p.K152E | Q6ZMV8 | protein_coding | deleterious(0.04) | benign(0.05) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
ZNF730 | SNV | Missense_Mutation | novel | c.299N>C | p.Leu100Pro | p.L100P | Q6ZMV8 | protein_coding | tolerated(0.08) | benign(0.173) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |